Viewing Study NCT01681992


Ignite Creation Date: 2025-12-24 @ 3:39 PM
Ignite Modification Date: 2026-01-02 @ 6:11 AM
Study NCT ID: NCT01681992
Status: COMPLETED
Last Update Posted: 2021-01-07
First Post: 2012-09-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life
Sponsor:
Organization: